These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32499112)

  • 1. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
    Ahmad W; Shabbiri K; Ahmad I
    Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of tau protein O-glycosylation in Alzheimer's disease.
    Robertson LA; Moya KL; Breen KC
    J Alzheimers Dis; 2004 Oct; 6(5):489-95. PubMed ID: 15505370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
    Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
    Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease.
    Liu F; Zaidi T; Iqbal K; Grundke-Iqbal I; Merkle RK; Gong CX
    FEBS Lett; 2002 Feb; 512(1-3):101-6. PubMed ID: 11852060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary tangles and tau phosphorylation.
    Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
    Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation.
    El Hajjar L; Page A; Bridot C; Cantrelle FX; Landrieu I; Smet-Nocca C
    Biochemistry; 2024 Jun; 63(12):1513-1533. PubMed ID: 38788673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
    Yuzwa SA; Vocadlo DJ
    Methods Mol Biol; 2017; 1523():237-248. PubMed ID: 27975253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
    Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
    Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OGlcNAcylation and phosphorylation have opposing structural effects in tau: phosphothreonine induces particular conformational order.
    Brister MA; Pandey AK; Bielska AA; Zondlo NJ
    J Am Chem Soc; 2014 Mar; 136(10):3803-16. PubMed ID: 24559475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids from Stems and Leaves of
    Shengkai D; Yazhen S
    CNS Neurol Disord Drug Targets; 2022; 21(4):367-374. PubMed ID: 34455972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease.
    Yao PJ; Coleman PD
    J Neurosci; 1998 Apr; 18(7):2399-411. PubMed ID: 9502801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain.
    Takahashi M; Tsujioka Y; Yamada T; Tsuboi Y; Okada H; Yamamoto T; Liposits Z
    Acta Neuropathol; 1999 Jun; 97(6):635-41. PubMed ID: 10378383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.
    Brandt R; Gergou A; Wacker I; Fath T; Hutter H
    Neurobiol Aging; 2009 Jan; 30(1):22-33. PubMed ID: 17590239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.